Piper Sandler adjusted its stance on Q32 Bio Inc. (NASDAQ: QTTB), downgrading the biotech firm's stock rating from Overweight to Neutral and significantly reducing the price target to $4.00 from the ...

Piper Sandler reiterated their overweight rating on shares of CNO Financial Group (NYSE:CNO – Free Report) in a research ...

IDEXX Laboratories (NASDAQ:IDXX – Free Report) had its price objective upped by Piper Sandler from $435.00 to $510.00 in a research report report published on Monday morning,Benzinga reports. Piper ...

The U.S. Securities and Exchange Commission's (SEC) newly established Crypto Task Force is expected to provide much-needed regulatory clarity for institutional investors, according to a research note ...

Piper Sandler analyst David Westenberg maintained a Hold rating on Idexx Laboratories (IDXX – Research Report) today and set a price target of ...

Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Pliant Therapeutics (PLRX – Research Report) today and set a price target of ...

Microsoft Corporation's cloud computing platform, Azure's workloads could push its artificial intelligence revenue to $10 ...

MINNEAPOLIS, February 06, 2025--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, announced today that its board of directors has authorized the repurchase of up to $150 million of ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

He noted that advisory services accounted for over half of firmwide net revenues for the fourth consecutive year. Abraham stated that the company completed the acquisition of Aviditi Advisors, ...

As of 3:35:16 PM EST. Market Open. Piper Sandler Companies ( NYSE:PIPR ) Full Year 2024 Results Key Financial Results Revenue: US$1.53b (up 13% from FY... MINNEAPOLIS, January 23, 2025--Piper ...